Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Income from Continuing Operations came in at 273954482.12 in Q1 2026, up 98.81% year-on-year from 137796861.58 in Q1 2025, and down 68.54% quarter-over-quarter from 870704548.99 in Q4 2025.
Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 273954482.12 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 98.81% year-over-year to 273954482.12 in Q1 2026; TTM through Mar 2026 was 2198319225.45, a 22.08% decrease from a year earlier, with the FY2025 full-year figure at 1047639163.23, up 216.71% from the prior year.
- Income from Continuing Operations eased to 273954482.12 in Q1 2026 per PHG's latest filing, from 870704548.99 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1189960771.81 in Q2 2024 and bottomed at 1732215298.56 in Q3 2022.
- The 5-year median for Income from Continuing Operations is 46950494.28 (2022), against an average of 120654047.76.
- Across the five-year window, Income from Continuing Operations plunged 1231.31% in 2022 and soared 304.26% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 1643618505.49 in 2022, then soared by 56.93% to 707968460.11 in 2023, then jumped by 262.56% to 1150877245.98 in 2024, then dropped by 24.34% to 870704548.99 in 2025, then slumped by 68.54% to 273954482.12 in 2026.
- Per Business Quant, the three latest PHG Income from Continuing Operations figures stand at 273954482.12 (Q1 2026), 870704548.99 (Q4 2025), and 564653609.12 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 220.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.95 Mn |
| Dec 31, 2025 | 870.70 Mn |
| Sep 30, 2025 | 564.65 Mn |
| Jun 30, 2025 | 489.01 Mn |
| Mar 31, 2025 | 137.80 Mn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 342.64 Mn |
| Jun 30, 2024 | 1.19 Bn |
| Mar 31, 2024 | -857.14 Mn |
| Dec 31, 2023 | -707.97 Mn |
| Sep 30, 2023 | -435.44 Mn |
| Jun 30, 2023 | -582.57 Mn |
| Mar 31, 2023 | -743.83 Mn |
| Dec 31, 2022 | -1.64 Bn |
| Sep 30, 2022 | -1.73 Bn |
| Jun 30, 2022 | -46.95 Mn |
| Mar 31, 2022 | -320.99 Mn |
| Dec 31, 2021 | 145.28 Mn |
| Sep 30, 2021 | 304.26 Mn |
| Jun 30, 2021 | 25.29 Mn |